Cargando…

Editorial: Molecular genetics and therapeutic advances in renal carcinoma

Detalles Bibliográficos
Autores principales:	Nanus, David M., Finke, James H., George, Saby
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886057/ https://www.ncbi.nlm.nih.gov/pubmed/36727061 http://dx.doi.org/10.3389/fonc.2022.1119373

Ejemplares similares

Editorial: Advances in the Pathogenesis and Therapeutic Strategies for Nasopharyngeal Carcinoma
por: Yang, Kai-Bin, et al.
Publicado: (2021)

Editorial: Advances in genetics and molecular diagnosis in colorectal cancer
por: Islam, Farhadul, et al.
Publicado: (2023)

Recent advances in the management of renal cell carcinoma
por: Molina, Ana M., et al.
Publicado: (2016)

Editorial: Establishment of marker models for molecular typing of renal cell carcinoma
por: Jiang, Aimin, et al.
Publicado: (2023)

Editorial: Advances in genetics and molecular diagnosis in colorectal, stomach, and pancreatic cancer
por: Vaccaro, Carlos Alberto, et al.
Publicado: (2022)

Editorial: Epigenetics and molecular genetics of rare tumors
por: Tognon, Mauro, et al.
Publicado: (2022)

Editorial: Genetics and Molecular Mechanisms of Oral and Esophageal Squamous Cell Carcinoma
por: Qiao, Bin, et al.
Publicado: (2022)

Editorial: Immunotherapy in renal cell carcinoma
por: Gruenwald, Viktor, et al.
Publicado: (2022)

Editorial: Case reports in renal cell carcinoma
por: Zhuang, Tony Z., et al.
Publicado: (2023)

Models of Renal Cell Carcinoma Used to Investigate Molecular Mechanisms and Develop New Therapeutics
por: Shapiro, Daniel D., et al.
Publicado: (2022)

Editorial: Influences in the progression of renal cell carcinoma
por: Bacchiani, Mara, et al.
Publicado: (2022)

Recent advances in management of renal cancer
por: Shah, Jay H, et al.
Publicado: (2009)

Mitochondrial Ndufa4l2 Enhances Deposition of Lipids and Expression of Ca9 in the TRACK Model of Early Clear Cell Renal Cell Carcinoma
por: Laursen, Kristian B., et al.
Publicado: (2021)

Editorial: Advancements in Molecular Diagnosis and Treatment of Melanoma
por: Palmieri, Giuseppe, et al.
Publicado: (2021)

Editorial: Immune checkpoint inhibitors in renal cell carcinoma
por: Tykodi, Scott S., et al.
Publicado: (2023)

Editorial: Molecular Targets and Therapeutic Strategies in Gynecological Cancers
por: Lu, Ziwen, et al.
Publicado: (2022)

Editorial: The molecular mechanisms of metastasis and therapeutic resistance in breast cancer
por: Liang, Yuanke, et al.
Publicado: (2023)

Case Report: Immune Checkpoint Inhibitor-Induced Exuberant Tumor Inflammation With Accelerated Clinical Deterioration in Metastatic Renal Cell Carcinoma
por: Gopalakrishnan, Dharmesh, et al.
Publicado: (2021)

Editorial: Molecular Advances in Diagnosis and Treatment of CNS Tumors
por: Zhang, Zhao-Hui, et al.
Publicado: (2020)

Editorial: Advances in the Molecular Mechanisms in Gastrointestinal Tumorigenesis and Treatment
por: Zhang, Ruowen, et al.
Publicado: (2022)

Editorial: Advances in molecular targeted therapies of urologic cancers
por: Nitzsche, Bianca, et al.
Publicado: (2022)

Editorial: Long-non coding RNAs in renal cell carcinoma
por: Wang, Zongping, et al.
Publicado: (2022)

Editorial: Recent Advances in Diagnosis and Management of Urothelial Carcinoma
por: Ku, Ja Hyeon, et al.
Publicado: (2021)

Role of everolimus in the treatment of renal cell carcinoma
por: George, Saby, et al.
Publicado: (2009)

Editorial: Women in cancer molecular targets and therapeutics, volume II: 2022
por: Berindan-Neagoe, Ioana, et al.
Publicado: (2023)

Editorial: Advances in malignant pleural mesothelioma: Diagnosis, treatment, and molecular mechanisms
por: Mastromarino, Maria Giovanna, et al.
Publicado: (2023)

Editorial: Molecular advances in diagnosis and treatment of CNS tumors, volume II
por: Chen, Clark, et al.
Publicado: (2023)

Molecular Characterization of the Tumor Microenvironment in Renal Medullary Carcinoma
por: Tourigny, David S., et al.
Publicado: (2022)

Advances in the molecular characterization of multiple myeloma and mechanism of therapeutic resistance
por: Mejia Saldarriaga, Mateo, et al.
Publicado: (2022)

Advances in Renal Cell Carcinoma Drug Resistance Models
por: Xiang, Yien, et al.
Publicado: (2022)

Editorial: Advances in the treatment of chronic myeloid leukemia
por: Eşkazan, Ahmet Emre, et al.
Publicado: (2023)

Editorial: The ever-changing scenario of first line treatment of metastatic renal cell carcinoma
por: Vitale, Maria Giuseppa, et al.
Publicado: (2023)

Editorial: Molecular landscapes of human papillomavirus-related squamous cell carcinoma
por: Shen, Yujie, et al.
Publicado: (2023)

Paraneoplastic Hypereosinophilia in Locally Advanced Clear Cell Renal Carcinoma
por: Ellez, Halil İbrahim, et al.
Publicado: (2023)

The role and therapeutic significance of the anoikis pathway in renal clear cell carcinoma
por: Wang, Jin, et al.
Publicado: (2022)

Editorial: Advances in mathematical and computational oncology, volume III
por: Bebis, George, et al.
Publicado: (2023)

Editorial: The molecular landscape and promising therapeutic targets in aggressive B-cell non-Hodgkin lymphomas
por: Witte, Hanno Maximilian, et al.
Publicado: (2023)

Editorial: Advances in the Involvement of Human Papilloma Virus in Head and Neck Squamous Cell Carcinoma
por: Lechien, Jerome R., et al.
Publicado: (2022)

Third Generation Tyrosine Kinase Inhibitors and Their Development in Advanced Renal Cell Carcinoma
por: Bukowski, Ronald M.
Publicado: (2012)

Current Status of Tivozanib in the Treatment of Patients With Advanced Renal Cell Carcinoma
por: Sakellakis, Minas, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d1ft107o52ekcs17q0famrlaf7